Llwytho...
CAR-T cell Therapy for Non-Hodgkin Lymphomas: A New Treatment Paradigm
The majority of patients with B-cell non-Hodgkin lymphoma (NHL) can be cured with standard chemoimmunotherapy. However, patients who fail first line therapy have dismal outcomes, particularly if they have disease that is resistant to salvage therapy, including chemoimmunotherapy, radiation and/or au...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Adv Cell Gene Ther |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6880960/ https://ncbi.nlm.nih.gov/pubmed/31777773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acg2.54 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|